[NKTR]

Mid
보유종목에 대한 모든 정보 확인이 가능합니다. | 원문 보기
Mid 2026-10-13 03:38:30
Nektar, Protagonist, Shattuck are Leerink top picks in emerging immunology
Mid 2026-09-25 20:30:32
Nektar gains 5% as jury awards $90M plus interest in Lilly trial
Mid 2026-09-23 04:21:32
Nektar Therapeutics drops as jury deliberates in Eli Lilly patent dispute over Rezpeg
Mid 2026-08-14 12:31:10
Nektar outlines REZPEG Phase III timeline with mid-2028 data and 2029 BLA plan
Mid 2026-08-14 05:25:46
Nektar Therapeutics GAAP EPS of -$1.23 beats by $0.70, revenue of $10.13M misses by $0.34M
1 / 2